Groundbreaking study investigates vaccine response differences across gender and sex
NCT ID NCT06832514
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how a person's sex and gender might change their immune system's reaction to the meningitis B vaccine. Researchers will compare immune responses in transgender and cisgender adults aged 18 to 50. The goal is to better understand why men and women often respond differently to vaccines, which could improve future vaccination strategies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGOCOCCAL MENINGITIS, SEROGROUP B are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CEVAC, University Hospital Ghent, Belgium
RECRUITINGGhent, 9000, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hospital push could shield seniors from preventable diseases
- Dentists may treat patients differently based on gender identity, study suggests
- Meningitis b vaccine shows promise in children
- Teens' sleep habits may boost vaccine power
- Simple exercise test may reveal hidden risks in flu patients
- Nutrient sachets may boost vaccination rates in rural africa